Ralf Kircheis

6PUBLICATIONS
1CO-AUTHORS
Biomolecular modelling and designMedical infection agents (incl. prions)Nanotoxicology, health and safetyElectrical energy generation (incl. renewables, excl. photovoltaics)Greenhouse gas inventories and fluxes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2.

|May 25, 2024
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants.

Ralf Kircheis

|Apr 13, 2023
The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation.

Ralf Kircheis, Oliver Planz

|Jun 10, 2022
Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?

Ralf Kircheis, Oliver Planz

|Oct 13, 2021
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.

Ralf Kircheis

|Sep 28, 2021
COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway.

Ralf Kircheis, Manfred Schuster, Oliver Planz

Pageof 1

Frequent Collaborators

2 joint publications

Oliver Planz